myomectomy techniques with laparoscopically assisted abdominal myomectomy (LAAM), a hybrid approach combining both laparoscopic and abdominal techniques using an ultra-minilaparotomy incision and bilateral uterine artery occlusion to control blood loss. MATERIALS AND METHODS: A retrospective chart review of 1380 patients undergoing myomectomy for benign indications at a community hospital from 2011 to 2013. Myomectomies performed via abdominal, conventional laparoscopic (CLM), robotic-assisted (RAM), and LAAM approaches were included in the study. Data collected included patient & leiomyoma characteristics, and surgical outcomes such as EBL, operating time (OT), length of stay (LOS), conversions to laparotomy and complications. Nonparametric Kruskal-Wallis tests were used to compare surgical outcomes across myomectomy techniques. Post hoc comparisons between LAAM and each of the other myomectomy approaches were performed using Bonferroni-adjusted Wilcoxon rank sum test. RESULTS: Patient characteristics were equally distributed among surgical groups. Average aggregate leiomyoma weight removed via LAAM technique was 389 gm, significantly larger than leiomyomas removed via CLM and RAM at 223 gm and 269 gm respectively (p < 0.001). When controlling for leiomyoma weight, LAAM had lowest average EBL among all surgical routes, 162 ml vs 181 ml for CLM, 166 ml for RAM, and 266 ml for abdominal approach. LAAM had the shortest OT with a mean of 73.9 min (p < 0.001) vs 101.6 min for CLM, 145.6 min for RAM and 96.8 min for abdominal. LAAM also had the shortest LOS at 0.4 days compared to 0.9 days for combined laparoscopic modalities and 2.5 days for abdominal (p < 0.001). The rate of conversion to mini-lap was highest for CLM at 20.9% vs 17.3% for RAM. Rate of conversion to laparotomy was also highest for CLM at 16.6% followed by RAM at 6.4% and lowest for LAAM at 0.6% (p < 0.001). Despite removal of higher leiomyoma volume in LAAM group, no difference in overall complication rates were noted between LAAM and combined LM approaches, but a statistically significant difference was noted between LAAM (10.0%) and abdominal group (19.9%, p < 0.015). LAAM also had the lowest direct hospital costs, which were primarily driven by operating room times and LOS. A second analysis examining only cases performed by high-volume surgeons revealed similar results. CONCLUSION: LAAM approach had higher total specimen weight removed, lower average EBL, shorter operating time, and comparable or lower complication rates when compared to other myomectomy techniques. LAAM as a cost effective minimally invasive technique overcomes the inherent technical challenges associated with laparoscopic myomectomy such as the inability to palpate small leiomyoma, limitation in tissue removal and uterine defect repair by combining the best benefits of abdominal and laparoscopic myomectomies.
OBJECTIVES: Known risks of surgical treatment for pelvic organ prolapse (POP) include intraoperative complications, unmasking stress urinary incontinence (SUI) and recurrent POP. We aimed to examine the rate and indications for reoperation after hysterectomy for POP. Specifically, we evaluated whether the type of apical support procedure affected the rate of and indications for reoperation.
MATERIALS AND METHODS:
This was an investigational review board approved retrospective study of all patients who underwent hysterectomy for POP within a large health care maintenance organization (HMO) in 2008. Surgeries were identified by procedural codes. The electronic medical record (EMR) was reviewed for demographic and clinical data, including apical procedures performed and reoperation details as available up to March 1, 2016. Data was analyzed using descriptive statistics. Inferential statistics with chi-squared tests were performed to compare reoperation rates. P-values less than 0.05 were considered statistically significant. RESULTS: Six hundred thirty hysterectomies for POP were performed in 2008 and had information available regarding performance of apical repair. Mean length of follow-up was 6.3 years (Standard Deviation ¼ 2.0 years). One hundred and nine patients (17%) underwent at least 1 subsequent related operation. Twenty-seven patients (4%) had subsequent operations with multiple indications (e.g. SUI and POP). Separate indications were addressed either in the same operation or multiple surgeries. Five hundred twelve patients (81%) had an apical repair at the time of hysterectomy for POP. Patients who had an apical repair were significantly more likely to undergo subsequent operation for SUI or another, non-POP or SUI related indication (such as voiding dysfunction or mesh exposure) compared to those who did not (Table 1) . Rates of reoperation for POP were similar regardless of performance of apical repair procedure. When type of apical support procedure was examined, there were no significant differences in the rates of reoperation by type of apical support procedure (Table 2) . CONCLUSION: In an HMO cohort with long-term follow-up, patients who had apical support procedures at time of hysterectomy for POP were significantly more likely to undergo subsequent operation for SUI. This finding is consistent with literature that demonstrates correction of apical prolapse can unmask occult SUI. The increased rate of reoperation for non-POP or SUI indications when apical prolapse repair is performed suggests additional morbidity may be associated with the apical procedure itself or its concurrent procedures. This merits further investigation.
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18 How has the U.S. Food and Drug Administration morcellation warning affected rates of minimally invasive hysterectomy in a large multi-center managed care setting?
S. Saadat, D. Arden OB/GYN, Kaiser Permanente, Beverly Hills, CA OBJECTIVES: Hysterectomy is the most common major gynecologic procedure in the world. Minimally invasive surgery is preferred to laparotomy due to its well-known benefits including lower blood loss, fewer perioperative complications, shorter hospital stay, quicker recovery time, and better cosmetic results. In 2014, the FDA issued a warning against the use of laparoscopic power morcellation in the majority of women undergoing myomectomy and hysterectomy for the treatment of fibroids, citing the risk of dissemination of an occult malignancy. Since the FDA statement, many institutions have banned or restricted the use of power morcellators. This study evaluated patients undergoing hysterectomy between April 17, 2014 and April 17, 2016. We compared the rate of hysterectomy via laparotomy vs. minimally invasive surgery (laparoscopic or vaginal) one year before and two years after the FDA warning. MATERIALS AND METHODS: This is a retrospective time-series analysis on all the hysterectomies performed for benign indications at Southern California Kaiser Foundation Hospitals between April 17, 2014 and April 17, 2016. Rate of abdominal vs. minimally invasive hysterectomies, estimated blood loss, length of operation and hospital stay, major post-operative complications, and hospital readmission within 30 days of surgery were compared in the one year before and the second year after the FDA warning. Post-operative complications included infection (superficial and deep), deep vein thrombosis, pulmonary embolism, wound dehiscence, fistula formation, and other unspecified post-operative complications. Analysis was performed using student T-test, ANOVA, and chisquared test for categorical variables. RESULTS: There were 18,252 hysterectomies performed in the three year study period. Those with missing records, age <18, pregnancy, and malignancy were excluded leaving 12,565 cases. Compared to one year before, there was a 5.4% and 5% increase in the rate of hysterectomies performed via laparotomy in the first year and second year after the FDA warning respectively (p < 0.001). There was no increase in the estimated blood loss, operative time, length of hospital stay, rate of re-admission, and post-operative complications (except pulmonary embolism). Similar results were obtained when sub-analysis was performed for hysterectomies with fibroid uterus as an indication for surgery. CONCLUSION: There was an increase in the rate of laparotomy for hysterectomy after the FDA morcellation warning. Despite this relative increase, there is no significant increase in the rate of immediate (30 day) post-operative complications or length of operation or hospital stay. This study did not assess parameters such as length of recovery or pain after surgery.
Saba Saadat: Nothing to disclose; Deborah Arden: Nothing to disclose.
19 Randomized controlled trial of two voiding trials after midurethral sling with or without colporrhaphy 
MATERIALS AND METHODS:
After enrollment, patients scheduled for outpatient MUS AE colporrhaphy were randomized to FOS or SVT. Patients were withdrawn if admitted or sustained cystotomy. Primary outcome was number of UPOV for voiding dysfunction or UTI. Voiding dysfunction is defined as urinary retention or postvoid residual (PVR) >200 cc. Secondary outcomes were catheterization after failed voiding trial (VT) & symptom assessment via the UDI-6 & AUA-SS. Retrograde-fill VT was performed in PACU at 1-hr (FOS) and within 2-3 hr (SVT). Force of urinary stream was recorded using a 100-point VAS, but used for research only in the SVT group. SVT subjects with a voided volume !2/3 instilled volume were discharged without a catheter. FOS subjects were discharged without a catheter if VAS was !50%; if <50% and PVR 499 cc, subjects were discharged with no catheter. Demographics, preoperative urodynamics, total recovery time, intraoperative and voiding trial data were collected. Follow-up time was 6-weeks. The criterion for noninferiority was an upper limit of <10% for the 90% CI. Analyses were performed using SAS version 9.4 (SAS Institute. Cary, NC). RESULTS: 102 subjects were included in the final analysis (49 FOS, 53 SVT). Demographics, prolapse stage, MUS type and concomitant surgery were similar in both groups. Immediate postoperative catheterization rates for FOS & SVT arms were 8.2% (n ¼ 4) and 9.4% (n ¼ 5) respectively (p ¼ 1.0000). PACU time was significantly less in the FOS group (2.1 h) compared to the SVT group (3.2 h)
